May 8, 2018 / 12:15 PM / 2 months ago

BRIEF-Aeglea Biotherapeutics Qtrly Loss Per Share $0.49

May 8 (Reuters) - Aeglea Bio Therapeutics Inc:

* AEGLEA BIOTHERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* QTRLY LOSS PER SHARE $0.49

* AS OF MARCH 31, 2018, AEGLEA HAD AVAILABLE CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $43.5 MILLION

* CO BELIEVES IT HAS SUFFICIENT CAPITAL RESOURCES TO FUND ANTICIPATED OPERATIONS THROUGH THE MIDDLE OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below